ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 59 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,000 | -48.3% | 72,367 | -39.4% | 0.00% | -50.0% |
| Q2 2022 | $29,000 | +16.0% | 119,460 | +168.9% | 0.00% | -33.3% |
| Q4 2021 | $25,000 | -34.2% | 44,419 | +18.1% | 0.00% | 0.0% |
| Q3 2021 | $38,000 | -60.0% | 37,597 | -32.6% | 0.00% | -57.1% |
| Q1 2021 | $95,000 | -26.4% | 55,798 | -38.6% | 0.01% | -68.2% |
| Q3 2020 | $129,000 | +330.0% | 90,812 | +271.6% | 0.02% | +633.3% |
| Q2 2020 | $30,000 | -60.5% | 24,437 | +23.7% | 0.00% | -40.0% |
| Q3 2018 | $76,000 | -42.0% | 19,755 | -49.0% | 0.01% | -16.7% |
| Q2 2018 | $131,000 | -28.8% | 38,721 | -55.7% | 0.01% | -40.0% |
| Q1 2018 | $184,000 | +53.3% | 87,478 | +47.8% | 0.01% | +66.7% |
| Q4 2017 | $120,000 | +172.7% | 59,184 | +187.9% | 0.01% | 0.0% |
| Q2 2017 | $44,000 | – | 20,557 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |